Skip to main content
. 2021 Dec 22;2021:2804521. doi: 10.1155/2021/2804521

Figure 24.

Figure 24

Structural characteristics that seem to favour the 3-SC antiviral activity against serotype 1B of human rhinovirus (HRV).